Report

reporttype1Version of Safety Report ID2receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10028731serious1Date Last Updated21/03/2014receiptdateformat102companynumbUS-009507513-0705USA02655occurcountryUSseriousnessother1duplicate1Date Received21/03/2014seriousnesshospitalization1transmissiondate02/10/2014primarysourcecountryUSseriousnessdisabling1

Primary Source

reportercountryUSqualification1

Patient

Weight64.41SexFemale

Reaction

1)

reactionmeddraversionpt17.0ReactionOsteomyelitisOutcomeRecovering/resolving

2)

reactionmeddraversionpt17.0ReactionOsteonecrosis of jawOutcomeRecovering/resolving

3)

reactionmeddraversionpt17.0ReactionDepressionOutcomeUnknown

4)

reactionmeddraversionpt17.0ReactionAnxietyOutcomeUnknown

5)

reactionmeddraversionpt17.0ReactionHerpes zosterOutcomeUnknown

6)

reactionmeddraversionpt17.0ReactionAcute sinusitisOutcomeUnknown

7)

reactionmeddraversionpt17.0ReactionLymphadenitisOutcomeUnknown

8)

reactionmeddraversionpt17.0ReactionChondrocalcinosis pyrophosphateOutcomeRecovering/resolving

9)

reactionmeddraversionpt17.0ReactionOral herpesOutcomeUnknown

10)

reactionmeddraversionpt17.0ReactionPharyngeal cystOutcomeUnknown

11)

reactionmeddraversionpt17.0ReactionRib fractureOutcomeUnknown

12)

reactionmeddraversionpt17.0ReactionThoracic vertebral fractureOutcomeRecovering/resolving

13)

reactionmeddraversionpt17.0ReactionOesophageal candidiasisOutcomeUnknown

14)

reactionmeddraversionpt17.0ReactionImpaired gastric emptyingOutcomeUnknown

15)

reactionmeddraversionpt17.0ReactionRheumatoid arthritisOutcomeNot recovered/not resolved

16)

reactionmeddraversionpt17.0ReactionLarge intestine polypOutcomeUnknown

17)

reactionmeddraversionpt17.0ReactionHypertensionOutcomeUnknown

18)

reactionmeddraversionpt17.0ReactionBone disorderOutcomeUnknown

19)

reactionmeddraversionpt17.0ReactionFractureOutcomeUnknown

20)

reactionmeddraversionpt17.0ReactionFallOutcomeUnknown

21)

reactionmeddraversionpt17.0ReactionFoot deformityOutcomeUnknown

22)

reactionmeddraversionpt17.0ReactionArthropathyOutcomeUnknown

23)

reactionmeddraversionpt17.0ReactionSpinal osteoarthritisOutcomeUnknown

24)

reactionmeddraversionpt17.0ReactionOsteopeniaOutcomeUnknown

25)

reactionmeddraversionpt17.0ReactionDry eyeOutcomeUnknown

26)

reactionmeddraversionpt17.0ReactionHypoaesthesiaOutcomeUnknown

27)

reactionmeddraversionpt17.0ReactionFatigueOutcomeUnknown

28)

reactionmeddraversionpt17.0ReactionWeight decreasedOutcomeUnknown

29)

reactionmeddraversionpt17.0ReactionHypoaesthesiaOutcomeUnknown

30)

reactionmeddraversionpt17.0ReactionParaesthesiaOutcomeUnknown

31)

reactionmeddraversionpt17.0ReactionDysphagiaOutcomeUnknown

32)

reactionmeddraversionpt17.0ReactionDyspepsiaOutcomeUnknown

33)

reactionmeddraversionpt17.0ReactionBlood calcium increasedOutcomeUnknown

34)

reactionmeddraversionpt17.0ReactionArthropathyOutcomeUnknown

35)

reactionmeddraversionpt17.0ReactionTendon disorderOutcomeUnknown

36)

reactionmeddraversionpt17.0ReactionInsomniaOutcomeUnknown

Drug

1)

drugcharacterization1medicinalproductFOSAMAXdrugauthorizationnumb020560drugstructuredosagenumb70drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition803drugdosagetext70 MG, QWdrugdosageformTABLETdrugadministrationroute048drugindicationOSTEOPOROSISdrugstartdateformat610drugstartdate/03/1998drugenddateformat610drugenddate/05/2006actiondrug4

openFDA Info on Medication

Application NumberNDA020560Brand NameFOSAMAXGeneric NameALENDRONATE SODIUMManufacturersMerck Sharp & Dohme Corp.product_ndc0006-0031Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsALENDRONATE SODIUMRXCUI904431, 904433spl_id37333f48-be6f-455d-878b-328bc51259c4spl_set_idf2dcfb39-a7c2-4e39-9e35-852a3a74f947Package NDC0006-0031-44UNII2UY4M2U3RA

2)

drugcharacterization1medicinalproductFOSAMAXdrugauthorizationnumb020560drugstructuredosagenumb10drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext10 MG, QDdrugdosageformTABLETdrugadministrationroute048drugindicationSPINAL COMPRESSION FRACTUREdrugstartdateformat102drugstartdate04/11/1999drugenddateformat102drugenddate06/10/2002actiondrug4

openFDA Info on Medication

3)

drugcharacterization2medicinalproductMORPHINEdrugindicationSPINAL COMPRESSION FRACTUREdrugstartdateformat602drugstartdate//1998drugenddateformat602drugenddate//2006

openFDA Info on Medication

Brand NameOPIUM TINCTURE DEODORIZEDGeneric NameMORPHINEManufacturersEdenbridge Pharmaceuticals, LLCproduct_ndc42799-217Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsMORPHINERXCUI830196spl_id5b376952-010f-adfc-e053-2a91aa0ae464spl_set_ide2a5697a-cc41-4cf1-b3a8-59b0268740d7Package NDC42799-217-01, 42799-217-02NUIN0000175684, N0000175690Mechanism of ActionFull Opioid Agonists [MoA]Established Pharmacologic ClassOpioid Agonist [EPC]UNII76I7G6D29C

4)

drugcharacterization2medicinalproductZOLOFTdrugindicationDEPRESSIONdrugstartdateformat602drugstartdate//1998

openFDA Info on Medication

Application NumberNDA020990, NDA019839Brand NameZOLOFTGeneric NameSERTRALINE HYDROCHLORIDEManufacturersRoerigproduct_ndc0049-0050, 0049-4960, 0049-4900, 0049-4910Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI208149, 208161, 212233, 312938, 312940, 312941, 861064, 861066spl_id665a145d-44fb-4fef-a3c1-2aac26e0715cspl_set_idfe9e8b7d-61ea-409d-84aa-3ebd79a046b5Package NDC 0049-4960-30, 0049-4960-50, 0049-4900-30, 0049-4900-66, 0049-4900-73, 0049-4900- ... UNIIUTI8907Y6X

5)

drugcharacterization2medicinalproductMETICORTENdrugstructuredosagenumb10drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext10 MG, QDdrugdosageformTABLETdrugstartdateformat102drugstartdate01/01/1988drugrecurreadministration3

Report Duplicate

duplicatesourceMERCKduplicatenumbUS-009507513-0705USA02655

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

8)

9)

10)

11)

12)

13)

14)

15)

16)

17)

18)

19)

20)

21)

22)

23)

24)

25)

26)

27)

28)

29)

30)

31)

32)

33)

34)

35)

36)

Drug

1)

openFDA Info on Medication

2)

openFDA Info on Medication

3)

openFDA Info on Medication

4)

openFDA Info on Medication

5)

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us